NCT06804889View on ClinicalTrials.gov

Effect of CBD-Based Vaginal Suppositories on Menopausal Symptoms

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

January 1, 2024

Study Completion Date

February 1, 2024

Conditions
Menopause and Genitourinary Syndrome
Interventions
DEVICE

CANNEFF® VAG SUP vaginal suppositories

CANNEFF® VAG SUP vaginal suppositories containing 100 mg cannabidiol - CBD and 6.6 mg hyaluronic acid - HA.

DEVICE

Placebo Suppositories

Received placebo vaginal suppositories with identical composition as for Active Comparator, but without both active ingredients (CBD - cannabidiol and HA - hyaluronic acid).

Trial Locations (1)

180 00

Gynaecology and Obstetrics Clinic Meda, Prague

All Listed Sponsors
collaborator

CB21 Pharma Ltd.

UNKNOWN

lead

Palacky University

OTHER